Abstract
AbstractAcquisition duration of correlated spectroscopy in vivo can be longer due to a large number of t1 increments along the indirect (F1) dimension. Limited number of t1 increments on the other hand leads to poor spectral resolution along F1. Covariance transformation (CT) instead of Fourier transform along t1 is an alternative way of increasing the resolution of the 2D COSY spectrum. Prospectively undersampled five-dimensional echo-planar correlated spectroscopic imaging (EP-COSI) data from ten malignant patients and ten healthy women were acquired and reconstructed using compressed sensing. The COSY spectrum at each voxel location was then generated using FFT, CT and a variant of CT called Inner Product (IP). Metabolite and lipid ratios were computed with respect to water from unsuppressed one-dimensional spectrum. The effects of t1-ridging artifacts commonly seen with FFT were not observed with CT/IP. Statistically significant differences were observed in the fat cross peaks measured with CT/IP/FFT. Spectral resolution was increased ~ 8.5 times (~ 19.53 Hz in FFT, ~ 2.32 Hz in CT/IP) without affecting the spectral width along F1 was possible with CT/IP. CT and IP enabled substantially increased F1 resolution effectively with significant gain in scan time and reliable measure of unsaturation index as a biomarker for malignant breast cancer.
Funder
CDMRP Breast Cancer Research Program
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Aboagye, E. O. & Bhujwalla, Z. M. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res. 59(1), 80–84 (1999).
2. Bolan, P. J. et al. MR spectroscopy of breast cancer for assessing early treatment response: Results from the ACRIN 6657 MRS trial. J. Magn. Reson. Imaging 46(1), 290–302 (2017).
3. Dorrius, M.D., Pijnappel, R.M., Jansen-van der Weide, M.C., Jansen, L., Kappert, P., Oudkerk, M., et al. Determination of choline concentration in breast lesions: quantitative multivoxel proton MR spectroscopy as a promising noninvasive assessment tool to exclude benign lesions. New diagnostic developments to prevent unnecessary invasive procedures in breast cancer diagnostic work-up. 2011.
4. Gribbestad, I., Sitter, B., Lundgren, S., Krane, J. & Axelson, D. Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy. Anticancer Res. 19(3A), 1737–1746 (1999).
5. Haukaas, T. H., Euceda, L. R., Giskeødegård, G. F. & Bathen, T. F. Metabolic portraits of breast cancer by HR MAS MR spectroscopy of intact tissue samples. Metabolites 7(2), 18 (2017).